| Pharmaceutical active ingredients: |
| Diatrizoate Meglumine |
| Available forms, composition and doses of Diatrizoate Meglumine: |
| Injectable; Injection; Diatrizoate Meglumine 76% |
| Diatrizoate Meglumine medical category: |
| Human:Roentgenography |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V08AA01 - Diatrizoic Acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| International Medication Systems |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cephalothin | Cephalothin Sodium | International Medication Systems |
| Dexamethasone | Dexamethasone Sodium Phosphate | International Medication Systems |
| Dextrose 25% | Dextrose | International Medication Systems |
| Dextrose 5% | Dextrose | International Medication Systems |
| Dextrose 50% | Dextrose | International Medication Systems |
| Diatrizoate-60 | Diatrizoate Meglumine; Diatrizoate Sodium | International Medication Systems |
| Diltiazem | Diltiazem Hydrochloride | International Medication Systems |
| Diphenhydramine | Diphenhydramine Hydrochloride | International Medication Systems |
| Diphenhydramine preservative free | Diphenhydramine Hydrochloride | International Medication Systems |
| Dopamine | Dopamine Hydrochloride | International Medication Systems |